{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:14:20Z","timestamp":1790709260406,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1124\/jpet.120.265447","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T21:15:28Z","timestamp":1587676528000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice"],"prefix":"10.1016","volume":"374","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-1341","authenticated-orcid":false,"given":"Corinne G.","family":"Jolivalt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie E.","family":"Frizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Madi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie S.","family":"Guernsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-4637","authenticated-orcid":false,"given":"Lakshmi P.","family":"Kotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-1201","authenticated-orcid":false,"given":"Paul","family":"Fernyhough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-8195","authenticated-orcid":false,"given":"Nigel A.","family":"Calcutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.265447_bib1","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00125-019-4897-y","article-title":"Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation","volume":"62","author":"Azmi","year":"2019","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.120.265447_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2008.06.079","article-title":"Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice","volume":"442","author":"Beiswenger","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.120.265447_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.irn.2016.02.011","article-title":"The perfect clinical trial","volume":"127","author":"Bril","year":"2016","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/jpet.120.265447_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(98)00692-2","article-title":"Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nerves","volume":"254","author":"Calcutt","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.120.265447_bib5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1172\/JCI88321","article-title":"Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy","volume":"127","author":"Calcutt","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.120.265447_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(99)02345-8","article-title":"Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats","volume":"856","author":"Calcutt","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/jpet.120.265447_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003495-198530020-00001","article-title":"Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases","volume":"30","author":"Carmine","year":"1985","journal-title":"Drugs"},{"key":"10.1124\/jpet.120.265447_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.irn.2019.04.002","article-title":"Role of mitochondria in diabetic peripheral neuropathy: influencing the NAD+-dependent SIRT1-PGC-1\u03b1-TFAM pathway","volume":"145","author":"Chandrasekaran","year":"2019","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/jpet.120.265447_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.120.265447_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jns5.12044","article-title":"Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin","volume":"18","author":"Chen","year":"2013","journal-title":"J Peripher Nerv Syst"},{"key":"10.1124\/jpet.120.265447_bib11","doi-asserted-by":"crossref","first-page":"431980","DOI":"10.1155\/2009\/431980","article-title":"The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy","volume":"2009","author":"Davidson","year":"2009","journal-title":"Exp Diabetes Res"},{"key":"10.1124\/jpet.120.265447_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0169-328X(94)90391-3","article-title":"Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor","volume":"21","author":"Diemel","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/jpet.120.265447_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0165-6147(00)01737-5","article-title":"Therapeutic opportunities from muscarinic receptor research","volume":"22","author":"Eglen","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.120.265447_bib14","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.drudis.2019.08.009","article-title":"Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders","volume":"24","author":"Erskine","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.120.265447_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11892-015-0671-9","article-title":"Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events","volume":"15","author":"Fernyhough","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1124\/jpet.120.265447_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-4522(94)90368-9","article-title":"Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment","volume":"62","author":"Fernyhough","year":"1994","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.120.265447_bib17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1124\/jpet.105.084855","article-title":"Cholinergic stimulation of amylase secretion from pancreatic acinar cells studied with muscarinic acetylcholine receptor mutant mice","volume":"313","author":"Gautam","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.265447_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000209255","article-title":"Muscarinic receptor subtypes in the lower urinary tract","volume":"83","author":"Giglio","year":"2009","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.120.265447_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-2982.2009.01456.x","article-title":"Localization of muscarinic receptors M1R, M2R and M3R in the human colon","volume":"22","author":"Harrington","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1124\/jpet.120.265447_bib20","first-page":"35","article-title":"Cerebro-spinal fluid concentrations of pirenzepine after therapeutic dosage","volume":"66","author":"Jaup","year":"1980","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1124\/jpet.120.265447_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cpmo.11","article-title":"Peripheral neuropathy in mouse models of diabetes","volume":"6","author":"Jolivalt","year":"2016","journal-title":"Curr Protoc Mouse Biol"},{"key":"10.1124\/jpet.120.265447_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/dom.12477","article-title":"Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice","volume":"17","author":"Jolivalt","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.120.265447_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00210-008-0365-9","article-title":"Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice","volume":"379","author":"Jositsch","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.120.265447_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0306-4522(02)00372-X","article-title":"Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats","volume":"114","author":"Khan","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.120.265447_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0026-895X(24)12299-7","article-title":"Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors","volume":"60","author":"Krajewski","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.265447_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.120.265447_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.0022-202X.2004.23425.x","article-title":"Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin","volume":"123","author":"Kurzen","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.120.265447_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/jop.1994.10.587","article-title":"Feasibility of insulin eyedrops for human use","volume":"10","author":"Liu","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1124\/jpet.120.265447_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jnr.20874","article-title":"Rat Schwann cells express M1-M4 muscarinic receptor subtypes","volume":"84","author":"Loreti","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.120.265447_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/B978-0-444-53480-4.00016-3","article-title":"Pathology of human diabetic neuropathy","volume":"126","author":"Malik","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1124\/jpet.120.265447_bib31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2019.10.007","article-title":"Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders","volume":"40","author":"Moran","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.120.265447_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1523-1747.1998.00299.x","article-title":"Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis","volume":"111","author":"Ndoye","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.120.265447_bib33","doi-asserted-by":"crossref","unstructured":"Oaklander AL, Nolano M (2019) Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol DOI: 10.1001\/jamaneurol.2019.2917 [published ahead of print]","DOI":"10.1001\/jamaneurol.2019.2917"},{"key":"10.1124\/jpet.120.265447_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/cxo.12887","article-title":"Corneal confocal microscopy: ready for prime time","volume":"103","author":"Petropoulos","year":"2019","journal-title":"Clin Exp Optom"},{"key":"10.1124\/jpet.120.265447_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.irn.2019.04.001","article-title":"Mitochondrial dysfunction in HIV-induced peripheral neuropathy","volume":"145","author":"Roda","year":"2019","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/jpet.120.265447_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fnins.2018.00402","article-title":"Muscarinic acetylcholine type 1 receptor activity constrains neurite outgrowth by inhibiting microtubule polymerization and mitochondrial trafficking in adult sensory neurons","volume":"12","author":"Sabbir","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1124\/jpet.120.265447_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.09.020","article-title":"Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons","volume":"143","author":"Sabbir","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.120.265447_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11934-009-0053-4","article-title":"The evolution of transdermal therapy for overactive bladder","volume":"10","author":"Sand","year":"2009","journal-title":"Curr Urol Rep"},{"key":"10.1124\/jpet.120.265447_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physiolgenomics.00062.2017","article-title":"Distribution and function of the muscarinic receptor subtypes in the cardiovascular system","volume":"50","author":"Saternos","year":"2018","journal-title":"Physiol Genomics"},{"key":"10.1124\/jpet.120.265447_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/B978-0-444-53480-4.00038-2","article-title":"Autonomic neuropathy in experimental models of diabetes mellitus","volume":"126","author":"Schmidt","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1124\/jpet.120.265447_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.toxicon.2011.08.004","article-title":"Muscarinic toxins","volume":"58","author":"Servent","year":"2011","journal-title":"Toxicon"},{"key":"10.1124\/jpet.120.265447_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0160-5402(90)90057-R","article-title":"Pharmacokinetics of muscarinic cholinergic drugs as determined by ex vivo (3H)-oxotremorine-M binding","volume":"23","author":"Sethy","year":"1990","journal-title":"J Pharmacol Methods"},{"issue":"Suppl 1","key":"10.1124\/jpet.120.265447_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000138507","article-title":"Clinical significance of M1 receptor antagonists","volume":"37","author":"Stockbr\u00fcgger","year":"1988","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.120.265447_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(00)02225-3","article-title":"Muscarinic receptors modulate intracellular calcium level in chick sensory neurons","volume":"866","author":"Tata","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/jpet.120.265447_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(00)00165-0","article-title":"Muscarinic receptor subtypes expression in rat and chick dorsal root ganglia","volume":"82","author":"Tata","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/jpet.120.265447_bib46","first-page":"3","article-title":"Muscarinic receptor subtypes in the alimentary tract","volume":"60","author":"Tobin","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/jpet.120.265447_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/bs.irn.2019.05.001","article-title":"Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy","volume":"145","author":"Trecarichi","year":"2019","journal-title":"Int Rev Neurobiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652425789X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652425789X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.265447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:54:43Z","timestamp":1739973283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652425789X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S002235652425789X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.265447","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.265447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}